Skip to main content

Table 1 Characteristics of biochemical data between controls and matched CAD patients

From: Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease

Characteristics

Controls (n = 220)

CAD (n = 426)

p value

Age (years)

62.00 (53.00–69.00)

61.00 (54.00–67.00)

0.178

Diabetes (%)

20.19

27.45

0.096

Hypertension (%)

48.40

51.6

0.650

hs-CRP (mg/dL)

0.46 (0.20–0.86)

2.28 (0.50–10.54)

< 0.001

WBC (109/L)

5.55 (4.83–6.45)

7.37 (5.93–9.06)

< 0.001

NEU (109/L)

3.57 (2.74–4.93)

4.69 (3.50–6.62)

< 0.001

Glucose (mmol/L)

5.45 (5.17–5.91)

5.80 (5.07–7.10)

< 0.001

TC (mmol/L)

3.90 (3.34–4.55)

4.34 (3.95–4.66)

< 0.001

TG (mmol/L)

1.09 (0.81–1.41)

1.45 (1.04–2.11)

< 0.001

HDL-c (mmol/L)

1.14 (1.01–1.30)

0.88 (0.76–1.07)

< 0.001

LDL-c (mmol/L)

2.13(1.64–2.71)

2.38 (2.04–2.64)

< 0.001

Testosterone (ng/dL)

466.27 (364.61–533.00)

292.02 (206.91–391.94)

< 0.001

GDF-15 (pg/mL)

347.99 (256.45–440.84)

775.07 (446.12–1113.19)

< 0.001

  1. Data are expressed as median (25th percentile–75th percentile); nominal data are given as percentages. Chi square (nominal data) or Mann–Whitney-U test (interval data) were performed to compare controls and CAD patients
  2. hs-CRP high-sensitivity C-reactive protein, WBC white blood cell, NEU neutrophil, TC total cholesterol, TG triglycerides, HDL-c high-density lipoprotein cholesterol, LDL-c low-density lipoprotein cholesterol, GDF-15 growth differentiation factor-15
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840